Rx Propellant Private Limited - Due diligence report

A 360° intelligence report on Rx Propellant: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2020-10-23 Shaikpet, Telangana Active Unlisted Active Compliant
Share
RP Rx Propellant Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rx Propellant — 360° Intelligence Report

Generated from MCA filings & public records
73/100
Trust Score
Moderate

Rx Propellant is assessed as Moderate with a Trust Score of 73/100. Rx Propellant is an active private limited indian non-government company incorporated in 2020, operating in the Life Sciences sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 22 Jul 2026 from the latest processed filings. Rx Propellant Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
90/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 90/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 auditor resignation(s) filed - latest: LAXMINIWAS & CO on 2022-11-21.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
PRAVEEN KUMAR POONAMALLEE SRIDHARAN 01234567 Director 01/04/2018 6 yrs Approved
MOHAMMED HAMEEDUDDIN FAROUQUI 01234567 Director 01/04/2018 6 yrs Approved
RICHARD STEPHEN MULLY 01234567 Director 01/04/2018 6 yrs Approved
DINESH MEEL 01234567 Director 01/04/2018 6 yrs Approved
RAGHVENDRA CHANDAK 01234567 Director 01/04/2018 6 yrs Approved
SANDHYA RANI SAMA 01234567 Director 01/04/2018 6 yrs Approved
ASHISH BALRAM SINGH 01234567 Director 01/04/2018 6 yrs Approved
BRIAN DAVID CHINAPPI 01234567 Director 01/04/2018 6 yrs Approved
Ashish Balram Singh 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • BRIAN DAVID CHINAPPI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Actis Rx 1 (mauritius) Limited (formerly Known Actis Treit 16p First (mauritius) Limited)
Subsidiaries
1
Group entities
1
Capital events
8 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Actis Rx 1 (mauritius) Limited (formerly Known Actis Treit 16p First (mauritius) Limited) Holding Company 74.00%
Jvrx Asset Management Private Limited Subsidiary Company 74.00%

Key managerial personnel: SANDHYA RANI SAMA (CFO) · ASHISH BALRAM SINGH (CEO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 director exits within 2 years.
1 auditor resignation(s) on record - review the stated reasons.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view39/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
24 Oct 2025
Director appointed
Ashish Balram Singh (Ceo)
22 Oct 2025
Director appointed
ASHISH BALRAM SINGH (CEO)
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
12 Sep 2024
Director ceased
DINESH MEEL
Director ceased
JASMEET SINGH CHHABRA
Director ceased
BRIAN DAVID CHINAPPI
07 May 2024
Director appointed
DINESH MEEL (Director)
08 Nov 2023
Director appointed
BRIAN DAVID CHINAPPI (Director)
27 Nov 2022
Securities allotted
7000000 Equity Shares - 7.00 cr raised
28 Sep 2022
Director ceased
RICHARD STEPHEN MULLY
11 Aug 2022
Securities allotted
7000000 Equity Shares - 7.00 cr raised
02 Aug 2022
Director appointed
MOHAMMED HAMEEDUDDIN FAROUQUI (Company Secretary)
29 Jul 2022
Director appointed
RICHARD STEPHEN MULLY (Director)
06 Jun 2022
Director appointed
SANDHYA RANI SAMA (CFO)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
9 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mindpool Consultants Private Limited U74140DL2007PTC160099 Delhi, Delhi, India
Rebalancing Labs Private Limited U29100HR2021PTC099825 Gurgaon, Haryana, India
Silicon Street Tech Private Limited U72900MH2021PTC352912 Kalyan, Maharashtra, India
Varun Medico Lab Private Limited U24239MH1996PTC099594 Thane, Maharashtra, India
Ronroz Private Limited U74999KL2020PTC062900 Petta, Kerala, India
Threefold Business Solutions Private Limited U74999DL2016PTC299363 New Delhi, Delhi, India
Pestalert Chemicals Pvt Ltd U51497WB1992PTC056848 Kolkatta, West Bengal, India
Nyassa Astrocorp Private Limited U74900DL2015PTC286327 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rx Propellant before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rx Propellant: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Rx Propellant - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Rx Propellant pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Rx Propellant - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rx Propellant an active company?

Rx Propellant has MCA status “Active” with a compliance score of 90/100 (Low Risk).

Is Rx Propellant financially healthy?

Rx Propellant has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Rx Propellant?

Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rx Propellant?

The ultimate holding entity is Actis Rx 1 (mauritius) Limited (formerly Known Actis Treit 16p First (mauritius) Limited). 9 active director(s) are on record.

Does Rx Propellant have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Rx Propellant up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 90/100 (Low Risk).

Is it risky to lend to Rx Propellant?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.